Franklin Resources’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Franklin Resources’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-469,793	Closed	-$2.98M	–	1582
2018 Q1	$2.98M	Hold	469,793	–	–	﹤0.01%	1124
2017 Q4	$3.79M	Sell	469,793 -33,936	-7%	-$316K	﹤0.01%	1119
2017 Q3	$5.76M	Sell	503,729 -2	-0%	-$21	﹤0.01%	1040
2017 Q2	$4.91M	Hold	503,731	–	–	﹤0.01%	1084
2017 Q1	$12.2M	Hold	503,731	–	–	0.01%	917
2016 Q4	$16.2M	Buy	503,731 +338,704	+205%	+$14.4M	0.01%	842
2016 Q3	$8.24M	Hold	165,027	–	–	﹤0.01%	1011
2016 Q2	$7M	Buy	+165,027	New	+$8.99M	﹤0.01%	1036

Other funds holding MACK

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

WIM

Wittenberg Investment Management Carlisle, Massachusetts $292M AUM 36.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Franklin Resources's MACK Position: Q2 2018 in Review

Franklin Resources sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2018, closing a stake of 469,793 shares — an estimated $2.98M sold.

Franklin Resources first reported a position in MACK in Q2 2016 and held it in 8 quarters. The position peaked at $16.2M in Q4 2016. 76 funds tracked by Wall St. Rank hold MACK as of Q2 2018.

Franklin Resources reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
Franklin Resources sold 469,793 Merrimack Pharmaceuticals, Inc. shares in Q2 2018, an estimated $2.98M.
Franklin Resources first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2016 and held it in 8 quarters.
Franklin Resources's Merrimack Pharmaceuticals, Inc. position peaked at $16.2M in Q4 2016.
76 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2018.

Based on Franklin Resources's 13F filing for Q2 2018, filed 14 Aug 2018.